Search

Brian E. Mcdowell

Examiner (ID: 5411, Phone: (571)270-5755 , Office: P/1624 )

Most Active Art Unit
1624
Art Unit(s)
4161, 1624
Total Applications
1663
Issued Applications
1042
Pending Applications
129
Abandoned Applications
533

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 16557107 [patent_doc_number] => 20210002255 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-07 [patent_title] => TLR7/8 ANTAGONISTS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/948432 [patent_app_country] => US [patent_app_date] => 2020-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40068 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16948432 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/948432
TLR7/8 antagonists and uses thereof Sep 17, 2020 Issued
Array ( [id] => 16557130 [patent_doc_number] => 20210002278 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-07 [patent_title] => BICYCLIC HETEROCYCLIC DERIVATIVES [patent_app_type] => utility [patent_app_number] => 17/023782 [patent_app_country] => US [patent_app_date] => 2020-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17046 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17023782 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/023782
Bicyclic heterocyclic derivatives Sep 16, 2020 Issued
Array ( [id] => 16557127 [patent_doc_number] => 20210002275 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-07 [patent_title] => PROCESS FOR PREPARATION OF PALBOCICLIB [patent_app_type] => utility [patent_app_number] => 17/019918 [patent_app_country] => US [patent_app_date] => 2020-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6899 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17019918 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/019918
PROCESS FOR PREPARATION OF PALBOCICLIB Sep 13, 2020 Abandoned
Array ( [id] => 16539318 [patent_doc_number] => 20200405731 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-31 [patent_title] => METHOD AND COMPOSITION FOR ADMINISTERING PROSTAGLANDINS [patent_app_type] => utility [patent_app_number] => 17/016158 [patent_app_country] => US [patent_app_date] => 2020-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22359 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17016158 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/016158
METHOD AND COMPOSITION FOR ADMINISTERING PROSTAGLANDINS Sep 8, 2020 Pending
Array ( [id] => 16525201 [patent_doc_number] => 20200399281 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-24 [patent_title] => PYRAZOLO[1,5-A]PYRAZIN-4-YL DERIVATIVES [patent_app_type] => utility [patent_app_number] => 17/014533 [patent_app_country] => US [patent_app_date] => 2020-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32595 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17014533 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/014533
Pyrazolo[1,5-a]pyrazin-4-yl derivatives Sep 7, 2020 Issued
Array ( [id] => 16688259 [patent_doc_number] => 20210070735 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-11 [patent_title] => RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME [patent_app_type] => utility [patent_app_number] => 17/012891 [patent_app_country] => US [patent_app_date] => 2020-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29341 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -31 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17012891 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/012891
RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME Sep 3, 2020 Abandoned
Array ( [id] => 17866957 [patent_doc_number] => 20220289692 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-15 [patent_title] => NLRP3 INHIBITORS [patent_app_type] => utility [patent_app_number] => 17/636021 [patent_app_country] => US [patent_app_date] => 2020-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29683 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17636021 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/636021
NLRP3 INHIBITORS Sep 3, 2020 Pending
Array ( [id] => 18725719 [patent_doc_number] => 20230339911 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-26 [patent_title] => PYRIDAZINONE COMPOUNDS [patent_app_type] => utility [patent_app_number] => 18/023241 [patent_app_country] => US [patent_app_date] => 2020-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19593 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18023241 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/023241
PYRIDAZINONE COMPOUNDS Aug 26, 2020 Pending
Array ( [id] => 17928264 [patent_doc_number] => 20220323389 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-13 [patent_title] => TREATING NON-ALCOHOLIC FATTY LIVER DISEASE AND INFLAMMATORY STEATOHEPATITIS WITH SLC25A1 INHIBITORS [patent_app_type] => utility [patent_app_number] => 17/638383 [patent_app_country] => US [patent_app_date] => 2020-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12434 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17638383 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/638383
TREATING NON-ALCOHOLIC FATTY LIVER DISEASE AND INFLAMMATORY STEATOHEPATITIS WITH SLC25A1 INHIBITORS Aug 25, 2020 Pending
Array ( [id] => 17193074 [patent_doc_number] => 11161814 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-11-02 [patent_title] => Compounds for modulating mitochondrial function [patent_app_type] => utility [patent_app_number] => 17/002308 [patent_app_country] => US [patent_app_date] => 2020-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 51 [patent_no_of_words] => 15132 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 168 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17002308 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/002308
Compounds for modulating mitochondrial function Aug 24, 2020 Issued
Array ( [id] => 16483913 [patent_doc_number] => 20200377514 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-03 [patent_title] => KV1.3 INHIBITORS AND THEIR MEDICAL APPLICATION [patent_app_type] => utility [patent_app_number] => 16/996502 [patent_app_country] => US [patent_app_date] => 2020-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25392 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16996502 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/996502
KV1.3 INHIBITORS AND THEIR MEDICAL APPLICATION Aug 17, 2020 Abandoned
Array ( [id] => 18187475 [patent_doc_number] => 11578042 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-02-14 [patent_title] => 3,5-diamino-6-chloro-N-(N-(4-(4-(2-(hexyl(2,3,4,5,6-pentahydroxyhexyl)amino)ethoxy)phenyl)butyl)carbamimidoyl)pyrazine-2-carboxamide [patent_app_type] => utility [patent_app_number] => 16/990176 [patent_app_country] => US [patent_app_date] => 2020-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 26940 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16990176 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/990176
3,5-diamino-6-chloro-N-(N-(4-(4-(2-(hexyl(2,3,4,5,6-pentahydroxyhexyl)amino)ethoxy)phenyl)butyl)carbamimidoyl)pyrazine-2-carboxamide Aug 10, 2020 Issued
Array ( [id] => 16452450 [patent_doc_number] => 20200361876 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-11-19 [patent_title] => PROCESS FOR THE PREPARATION OF DIPHENYLPYRAZINE DERIVATIVES [patent_app_type] => utility [patent_app_number] => 16/984467 [patent_app_country] => US [patent_app_date] => 2020-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3415 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16984467 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/984467
Process for the preparation of diphenylpyrazine derivatives Aug 3, 2020 Issued
Array ( [id] => 16452504 [patent_doc_number] => 20200361930 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-11-19 [patent_title] => BIFUNCTIONAL MOLECULES THAT DEGRADE EGFR [patent_app_type] => utility [patent_app_number] => 16/984987 [patent_app_country] => US [patent_app_date] => 2020-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7515 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16984987 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/984987
BIFUNCTIONAL MOLECULES THAT DEGRADE EGFR Aug 3, 2020 Abandoned
Array ( [id] => 17921569 [patent_doc_number] => 11464790 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-10-11 [patent_title] => Triterpenoids with HIV maturation inhibitory activity [patent_app_type] => utility [patent_app_number] => 16/983052 [patent_app_country] => US [patent_app_date] => 2020-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 52847 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16983052 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/983052
Triterpenoids with HIV maturation inhibitory activity Aug 2, 2020 Issued
Array ( [id] => 17665250 [patent_doc_number] => 11358931 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-06-14 [patent_title] => Selective androgen receptor modulators (SARMs) and uses thereof [patent_app_type] => utility [patent_app_number] => 16/983617 [patent_app_country] => US [patent_app_date] => 2020-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 63103 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16983617 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/983617
Selective androgen receptor modulators (SARMs) and uses thereof Aug 2, 2020 Issued
Array ( [id] => 18582834 [patent_doc_number] => 20230265089 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-24 [patent_title] => QUINOLINE DERIVATIVES, PHARMACEUTICALLY ACCEPTABLE SALTS, AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/003758 [patent_app_country] => US [patent_app_date] => 2020-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7969 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18003758 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/003758
QUINOLINE DERIVATIVES, PHARMACEUTICALLY ACCEPTABLE SALTS, AND METHODS OF USE THEREOF Jul 30, 2020 Pending
Array ( [id] => 16450912 [patent_doc_number] => 20200360338 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-11-19 [patent_title] => METHOD FOR ACTIVATING ENERGY METABOLISM IN MUSCLE CELLS BY ADMINISTERING TO HUMAN BEINGS AT LEAST ONE ACTIVE SUBSTANCE COMPRISING METHOXYFLAVONE [patent_app_type] => utility [patent_app_number] => 16/941633 [patent_app_country] => US [patent_app_date] => 2020-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4916 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -1 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16941633 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/941633
METHOD FOR ACTIVATING ENERGY METABOLISM IN MUSCLE CELLS BY ADMINISTERING TO HUMAN BEINGS AT LEAST ONE ACTIVE SUBSTANCE COMPRISING METHOXYFLAVONE Jul 28, 2020 Abandoned
Array ( [id] => 17882638 [patent_doc_number] => 20220298115 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-22 [patent_title] => SMALL MOLECULE INHIBITORS OF ACETYL COENZYME A SYNTHETASE SHORT CHAIN 2 (ACSS2) [patent_app_type] => utility [patent_app_number] => 17/629497 [patent_app_country] => US [patent_app_date] => 2020-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49080 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17629497 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/629497
SMALL MOLECULE INHIBITORS OF ACETYL COENZYME A SYNTHETASE SHORT CHAIN 2 (ACSS2) Jul 23, 2020 Abandoned
Array ( [id] => 17867052 [patent_doc_number] => 20220289787 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-15 [patent_title] => DIMER COMBINATIONS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/629733 [patent_app_country] => US [patent_app_date] => 2020-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39586 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17629733 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/629733
DIMER COMBINATIONS AND USES THEREOF Jul 23, 2020 Pending
Menu